Szkultecka-Dębek, M. et al. 2013. Adverse events (AE) costs assessed in Poland based on existing Drug Programs – methodology of the project. Current Issues in Pharmacy and Medical Sciences. 26, 4 (Dec. 2013), 422–424. DOI:https://doi.org/10.12923/j.2084-980X/26.4/a.16.